MEDANTA — Global Health Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Global Health, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	14,467	21,666	26,942	32,751	36,923
Cost of Revenue
Gross Profit	10,982	16,237	20,690	25,158	28,126
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	13,757	18,440	22,156	26,356	30,528
Operating Profit	711	3,226	4,787	6,395	6,395
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	325	2,806	4,493	6,271	6,473
Provision for Income Taxes
Net Income After Taxes	288	1,962	3,261	4,781	4,813
Minority Interest
Net Income Before Extraordinary Items
Net Income	288	1,962	3,261	4,782	4,814
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	288	1,962	3,261	4,782	4,814
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.06	7.25	12.6	17.8	19.3
Dividends per Share